Pharmaceutical News and Articles

FDA Approves Veppanu (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination

FRIDAY, May 1, 2026 Several powdered beverage mixes by Ghirardelli Chocolate Company are being recalled due to possible concerns of Salmonella contamination. Gh

U.S. Adults Interested in, but Lack Knowledge About, Brain Health

U.S. adults show strong interest in brain health, but very few report knowing a lot about ways to maintain a healthly brain, according to a special report, Brai

Positive Affect Treatment Outperforms Negative Affect Treatment in Depression, Anxiety

Positive affect treatment (PAT) engaging reward systems yields a greater improvement on clinical status than negative affect treatment (NAT) for adults with sev

Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds

FRIDAY, May 1, 2026 Many women might start breast cancer screening later than recommended because they aren t up to date on the latest guidelines, a new survey

Senses, Not Muscles, Key to Speech Recovery After Stroke

FRIDAY, May 1, 2026 A stroke victim s senses might matter as much as their muscles as they work to relearn how to talk, a new study says. Previously, experts th

Antibiotics Not Linked To Celiac Disease Risk, Study Argues

FRIDAY, May 1, 2026 Antibiotics don t appear to increase a person s risk of developing celiac disease, a new study says. Patients with celiac disease had a 24 h

Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination

FRIDAY, May 1, 2026 The White House has hit the reset button on its search for the next U.S. surgeon general. President Donald Trump announced Thursday that he

No Causal Link Found Between Celiac Disease and Antibiotic Exposure

Individuals with celiac disease (CD) are more often exposed to antibiotics before their diagnosis, but data suggest heightened surveillance rather than causalit

LFSPRO Model Shows Superior Discrimination for Li-Fraumeni Syndrome

LFSPRO, a Mendelian, family history-based model that estimates an individual s probability of harboring a deleterious TP53 variant, shows superior discriminatio